By: Mallory Bachmann The Norman Fixel Institute for Neurological Diseases at UF Health is welcoming five first-year movement disorders fellows for the 2026-27 academic year, marking the largest fellowship class in the program’s history. The incoming class surpasses the program’s typical class size of three fellows and…
By: Todd Taylor It has long been known that the brain’s ability to metabolize a simple form of sugar called glucose gradually decreases as we age, and there is increasing evidence that this is more pronounced in the brains of patients with Alzheimer’s disease. Now, a new University of Florida…
By: Jill Pease Dementia with Lewy bodies is notoriously difficult to diagnose. Symptoms can resemble several other conditions, leading to delayed or incorrect diagnoses. Until recently, the only way to confirm dementia with Lewy bodies was to test a person’s brain after death for the presence of abnormal clumps of…
By: Mallory Bachmann The Norman Fixel Institute for Neurological Diseases at UF Health is launching the Isa Elaine Foundation Brain Iron Disorders Care Program on July 30, a new multidisciplinary clinic dedicated to providing specialized care for children and adults living with neurodegeneration with brain iron accumulation (NBIA) and…
One challenge to advancing Alzheimer’s disease treatments is that many patients have mixed brain pathologies, meaning more than one disease process is affecting the brain. This can complicate diagnosis, clinical trial design and treatment development because a therapy targeting only one disease process may be less effective if another is…
GAINESVILLE, Fla. — New research has found an association between taking glucosamine, a popular over-the-counter supplement used for joint pain, and a higher likelihood of progressing from mild cognitive impairment to Alzheimer’s disease.
By: Mallory Bachmann When Lena Loyd arrived on campus her freshman year, she knew college would require a new level of independence. What she did not anticipate was how often she would draw on the self-advocacy skills she developed while learning to manage Tourette syndrome. When the Symptoms Began Halfway…
By: Alisha Katz Alzheimer’s disease and related dementias are expected to more than double by 2060. As June marks Alzheimer’s and Brain Awareness Month, three University of Florida researchers are working to improve clinicians’ ability to distinguish between these diseases — a critical step toward earlier diagnosis and better outcomes. …
